Spex Capital launches €100m fund for early stage healthtech ventures

27th February 2023

Digital health and med-tech investment firm Spex Capital has launched a new fund with a target size of €100m. The Spex Venture HealthTech Fund is a closed-end fund which will invest globally in early-stage healthtech ventures, from seed to Series A, up to €5m. Spex, which was founded in 2021 by serial health tech entrepreneur Claudio D’Angelo,…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?

Spex Capital launches €100m fund for early stage healthtech ventures

Membership Required

You must be a HM Subscriber to view this content.

Stay ahead of the market

Join our weekly newsletters

About LaingBuisson

Follow LaingBuisson

InHealth reports flat revenue as CDC expansion dents margins

Transactions in care home market continue to build, data shows

Government considering New Zealand-style tenure model